Drug intelligence / Profile preview

Yu Chai decoction

Development stage: Preclinical
Lead developer: Hunan Provincial Science and Technology Department
Administration: Oral

Overview

Yu Chai decoction is a Traditional Chinese Medicine (TCM) formulation currently under investigation as a first-line therapy for advanced breast carcinoma. It is being studied in a prospective clinical trial in combination with tamoxifen. The specific herbal composition and detailed mechanism of action of Yu Chai decoction are not explicitly detailed in the provided context.

Beyond the preview

Go deeper on Yu Chai decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yu Chai decoction.

Explore the full profile